{"entity":{"type":"insider","cik":"0001282199","url":"/insider/0001282199","json_url":"/insider/0001282199.json","name":"CONDELLA FRANK JR","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":9,"first":"2004-08-30","last":"2015-11-19","span_basis":"filed_date"},"name_variants":[{"name":"CONDELLA FRANK JR","source":"filing","n_filings":9,"first_seen":"2004-08-30","last_seen":"2015-11-19"}],"transactions":[{"id":8105825,"accession":"0001382963-15-000135","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001382963-15-000135","line_url":"/filing/0001382963-15-000135#line-1","is_derivative":false,"issuer_cik":"0000821995","issuer_name":"JUNIPER PHARMACEUTICALS INC","issuer_ticker":"JNP","issuer_name_source":null,"issuer_url":"/issuer/0000821995","owner_cik":"0001282199","owner_name":"CONDELLA FRANK JR","owner_display_name":"CONDELLA FRANK JR","owner_url":"/insider/0001282199","role":"Officer (President & CEO)","role_mark":"O","role_mark_label":"Officer (President & CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"common stock, par value $0.01","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":11.6804,"price_display":"11.68","price_state":"stated","total_value":58402.0,"total_display":"58,402.00","total_whole":"58,402","shares_owned_after":79720.0,"shares_owned_after_display":"79,720","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-18","filed_date":"2015-11-19","scope":"insider"},{"id":8535738,"accession":"0001209191-15-040974","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-040974","line_url":"/filing/0001209191-15-040974#line-1","is_derivative":false,"issuer_cik":"0000821995","issuer_name":"JUNIPER PHARMACEUTICALS INC","issuer_ticker":"JNP","issuer_name_source":null,"issuer_url":"/issuer/0000821995","owner_cik":"0001282199","owner_name":"CONDELLA FRANK JR","owner_display_name":"CONDELLA FRANK JR","owner_url":"/insider/0001282199","role":"Officer (President & CEO)","role_mark":"O","role_mark_label":"Officer (President & CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"JNP stock on Open Market","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":7.36,"price_display":"7.36","price_state":"stated","total_value":73600.0,"total_display":"73,600.00","total_whole":"73,600","shares_owned_after":65345.0,"shares_owned_after_display":"65,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-08","filed_date":"2015-05-11","scope":"insider"},{"id":6553960,"accession":"0001181431-14-029191","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-029191","line_url":"/filing/0001181431-14-029191#line-1","is_derivative":false,"issuer_cik":"0000821995","issuer_name":"COLUMBIA LABORATORIES INC","issuer_ticker":"CBRX","issuer_name_source":null,"issuer_url":"/issuer/0000821995","owner_cik":"0001282199","owner_name":"CONDELLA FRANK JR","owner_display_name":"CONDELLA FRANK JR","owner_url":"/insider/0001282199","role":"Officer (President & CEO)","role_mark":"O","role_mark_label":"Officer (President & CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"CBRX stock on Open Market","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":5.98,"price_display":"5.98","price_state":"stated","total_value":59800.0,"total_display":"59,800.00","total_whole":"59,800","shares_owned_after":55345.0,"shares_owned_after_display":"55,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-13","filed_date":"2014-08-14","scope":"insider"},{"id":6308200,"accession":"0001181431-14-017863","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-017863","line_url":"/filing/0001181431-14-017863#line-1","is_derivative":false,"issuer_cik":"0000821995","issuer_name":"COLUMBIA LABORATORIES INC","issuer_ticker":"CBRX","issuer_name_source":null,"issuer_url":"/issuer/0000821995","owner_cik":"0001282199","owner_name":"CONDELLA FRANK JR","owner_display_name":"CONDELLA FRANK JR","owner_url":"/insider/0001282199","role":"Officer (President & CEO)","role_mark":"O","role_mark_label":"Officer (President & CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"CBRX stock on Open Market","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":6.65,"price_display":"6.65","price_state":"stated","total_value":66500.0,"total_display":"66,500.00","total_whole":"66,500","shares_owned_after":45345.0,"shares_owned_after_display":"45,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-05","filed_date":"2014-05-05","scope":"insider"},{"id":4692622,"accession":"0001181431-13-060679","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-060679","line_url":"/filing/0001181431-13-060679#line-1","is_derivative":false,"issuer_cik":"0000821995","issuer_name":"COLUMBIA LABORATORIES INC","issuer_ticker":"CBRX","issuer_name_source":null,"issuer_url":"/issuer/0000821995","owner_cik":"0001282199","owner_name":"CONDELLA FRANK JR","owner_display_name":"CONDELLA FRANK JR","owner_url":"/insider/0001282199","role":"Officer (President & CEO)","role_mark":"O","role_mark_label":"Officer (President & CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"CBRX stock on Open Market","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":6.32,"price_display":"6.32","price_state":"stated","total_value":31600.0,"total_display":"31,600.00","total_whole":"31,600","shares_owned_after":35346.0,"shares_owned_after_display":"35,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-26","filed_date":"2013-11-26","scope":"insider"},{"id":5447129,"accession":"0001181431-13-027979","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-027979","line_url":"/filing/0001181431-13-027979#line-1","is_derivative":false,"issuer_cik":"0000821995","issuer_name":"COLUMBIA LABORATORIES INC","issuer_ticker":"CBRX","issuer_name_source":null,"issuer_url":"/issuer/0000821995","owner_cik":"0001282199","owner_name":"CONDELLA FRANK JR","owner_display_name":"CONDELLA FRANK JR","owner_url":"/insider/0001282199","role":"Officer (President & CEO)","role_mark":"O","role_mark_label":"Officer (President & CEO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"CBRX stock on Open Market","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":80000.0,"shares_display":"80,000","price_per_share":0.634,"price_display":"0.63","price_state":"stated","total_value":50720.0,"total_display":"50,720.00","total_whole":"50,720","shares_owned_after":242764.0,"shares_owned_after_display":"242,764","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-15","filed_date":"2013-05-15","scope":"insider"},{"id":7730359,"accession":"0001140361-10-012102","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-10-012102","line_url":"/filing/0001140361-10-012102#line-1","is_derivative":false,"issuer_cik":"0000821995","issuer_name":"COLUMBIA LABORATORIES INC","issuer_ticker":"CBRX","issuer_name_source":null,"issuer_url":"/issuer/0000821995","owner_cik":"0001282199","owner_name":"CONDELLA FRANK JR","owner_display_name":"CONDELLA FRANK JR","owner_url":"/insider/0001282199","role":"Director, Officer (Interim CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Interim CEO","security_title":"$.01 Par Value Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.1215,"price_display":"1.12","price_state":"stated","total_value":112150.0,"total_display":"112,150.00","total_whole":"112,150","shares_owned_after":162764.0,"shares_owned_after_display":"162,764","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-03-15","filed_date":"2010-03-16","scope":"insider"},{"id":1605463,"accession":"0001181431-05-033592","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001181431-05-033592","line_url":"/filing/0001181431-05-033592","is_derivative":false,"issuer_cik":"0000772197","issuer_name":"IVAX CORP","issuer_ticker":"IVX","issuer_name_source":null,"issuer_url":"/issuer/0000772197","owner_cik":"0001282199","owner_name":"CONDELLA FRANK JR","owner_display_name":"CONDELLA FRANK JR","owner_url":"/insider/0001282199","role":"Officer (Pres. IVAX Pharm. Europe)","role_mark":"O","role_mark_label":"Officer (Pres. IVAX Pharm. Europe)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Pres. IVAX Pharm. Europe","security_title":"Common Stock, $.10 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":56250.0,"shares_display":"56,250","price_per_share":19.6299,"price_display":"19.63","price_state":"stated","total_value":1104181.875,"total_display":"1,104,181.88","total_whole":"1,104,182","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-06-06","filed_date":"2005-06-08","scope":"insider","n_lines":2},{"id":558108,"accession":"0001181431-04-042219","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-04-042219","line_url":"/filing/0001181431-04-042219#line-2","is_derivative":false,"issuer_cik":"0000772197","issuer_name":"IVAX CORP","issuer_ticker":"IVX","issuer_name_source":null,"issuer_url":"/issuer/0000772197","owner_cik":"0001282199","owner_name":"CONDELLA FRANK JR","owner_display_name":"CONDELLA FRANK JR","owner_url":"/insider/0001282199","role":"Officer (President of IVAX UK)","role_mark":"O","role_mark_label":"Officer (President of IVAX UK)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President of IVAX UK","security_title":"Common Stock, $.10 par value per share","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37500.0,"shares_display":"37,500","price_per_share":20.0032,"price_display":"20.00","price_state":"stated","total_value":750120.0,"total_display":"750,120.00","total_whole":"750,120","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2004-08-26","filed_date":"2004-08-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":7,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000821995","name":"JUNIPER PHARMACEUTICALS INC","url":"/issuer/0000821995","role":"Director, Officer (President & CEO)","n_filings":7,"first_seen":"2010-03-16","last_seen":"2015-11-19"},{"type":"issuer","type_label":"ISSUER","cik":"0000772197","name":"IVAX CORP","url":"/issuer/0000772197","role":"Officer (Pres. IVAX Pharm. Europe)","n_filings":2,"first_seen":"2004-08-30","last_seen":"2005-06-08"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001282199","retrieved_at":"2026-08-22T16:08:40+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}